Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinkexian is a prominent Chinese biotechnology company specializing in the development and manufacture of high-quality recombinant proteins and cytokines. The company primarily serves the life sciences research and biopharmaceutical manufacturing sectors, with a particular emphasis on providing GMP-grade raw materials for cell and gene therapy (CGT) applications. Their extensive portfolio includes essential growth factors such as Interleukin-2, Interleukin-15, and various fibroblast growth factors used in the cultivation of CAR-T, TCR-T, and stem cells. Beyond its product offerings, Xinkexian provides comprehensive contract development and manufacturing services, including protein design, expression, and purification. The company's facilities are designed to meet international quality standards, supporting the transition of therapies from laboratory research to clinical production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinkexian.